Delivery Order SPE2DB20D9331-SPE2DB25FL1R7
- Not listed
- On August 18, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $32,499.90 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge, IL. This award represents a firm fixed-price delivery order under the company's larger Indefinite Delivery Contract with the DLA, valued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The award, issued on August 14, 2025, with an ultimate completion date of September 5, 2025, carries a firm fixed-price arrangement with no set-aside designation. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger...
- On August 1, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, which is scheduled for completion by August 22, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor on this award. The delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,499.90 to DMS Pharmaceutical Group Inc. on August 26, 2025, for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with a firm fixed-price contract structure and ultimate completion date of September 17, 2025. The contract carries no set-aside designation, allowing the vendor to compete directly...
- On June 18, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $32,499.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for Stelara 90 mg/mL syringes, with an ultimate completion date of July 11, 2025. This award utilizes a firm fixed-price contract type with no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal marketplace based on its...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, valued at $16,249.95, was awarded on September 2, 2025, with an ultimate completion date of September 23, 2025. The contract does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. The contract, designated as a firm fixed-price delivery order, was awarded on September 15, 2025, with an ultimate completion date of October 6, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group to...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. The award represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 28, 2025, for Stelara 90mg/ml syringes valued at $16,249.95. The contract is firm fixed-price with a completion date of September 18, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $16,249.95 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Stelara 90 mg/ml syringes. The contract carries an ultimate completion date of October 2, 2025, and does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1R7Delivery Order
This delivery order, issued on August 8, 2025, by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, covers the supply of Stelara 90 mg/ml syringes with a ceiling value of $16,249.95. The contract is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, and represents a specific pharmaceutical fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 through November 2026. No set-aside designation was applied to this delivery order. DMS Pharmaceutical Group leverages its established position within the federal pharmaceutical supply chain to provide critical medications and biologics to Department of Defense healthcare facilities. The company's comprehensive IDC with the DLA, established under the SPE2DB program, enables the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables. Stelara, an immunosuppressant biologic used in treating autoimmune conditions, represents one of many specialty medications the vendor supplies to military health facilities nationwide, reinforcing its role as a crucial distributor of prescription drugs and pharmacy services to DoD healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 8/8/25 |